CEUS are providing point of care stool behaviour monitorization for people with Irritable Bowel Syndrome.
This impairing disease, also referred to as IBS, has fluctuating activity levels.
By closely monitoring increase and decrease of the activity level, patients will gain control over their disease through Point of Care testing.
With Aphodius, doctors and patients are able to monitor the activity level of the disease in real-time,
resulting in better medical insight for the doctor and less pain for the patient.
The device is easily attached to the toilet bowl in the house of the patient.
Each toilet visit by the IBS-patient is being measured with the novel technology within Aphodius.
A combination of photonics and optical imaging makes it possible to collect valuable data without the need of physical interaction with the stool.
The data is then sent to the CEUS software for further analysis.
Multiple datapoints are filled in by the patient through their smartphone application. Combined with the data collected from Aphodius, CEUS calculates the activity level using Machine Learning.
Interested in learning more about the Technology Readiness Level?
The calculated result from Aphodius and software is then available in the smartphone application for the patient, enabling self-management for treatment of the disease.
The results are also provided in an intuitive dashboard for the Health Care Provider, if immediate medical care is needed.
In order to get to market with Aphodius, CEUS are to collaborate and work with the brightest companies and people around.
Are you interested in becoming a part of the journey – or would you like to be kept in the loop, in order to collaborate at a later time – then please contact us.